CellSource Co., Ltd.
CellSource Co., Ltd. scores highest on Torque (77) and lowest on Nitro (20). Its PosiPenta is 46.66 out of 100, around the middle of similar companies.
On the Penta Grid this week, CellSource Co., Ltd. is Grid #35 of 49 in the Healthcare sector in Japan, and Grid #676 of 986 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| CellSource Co., Ltd. | 46.66 | 42 | 60 | 20 | 77 | 35 |
| SUSMED,Inc. | 33.21 | 28 | 50 | 3 | 57 | 29 |
| Nippon Chemiphar Co., Ltd. | 36.69 | 50 | 13 | 41 | 22 | 58 |
| Hi-CRATES CO.,LTD. | 68.48 | 80 | 55 | 65 | 83 | 60 |
| Koken Ltd. | 60.00 | 90 | 80 | 33 | 39 | 58 |
| Yamashita Health Care Holdings,Inc. | 65.52 | 64 | 87 | 70 | 50 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 62.17 |
| P/B ratio | 1.01 |
EEarnings
| Trailing EPS | ₹3.01 |
| Forward EPS | ₹10.93 |
NNitro
| Price | 187.06 |
| 52-week high | 320.84 |
| 52-week low | 177.98 |
| Fall from 52-week high | 41.7% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | -0.01 |
| Market cap | ₹371 Cr |
| Insider holding | 54.26% |
| Dividend yield | 1.62% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is CellSource Co., Ltd.'s PosiPenta score?
CellSource Co., Ltd.'s PosiPenta is 46.66 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does CellSource Co., Ltd. stand on the Penta Grid?
On the Penta Grid this week, CellSource Co., Ltd. is Grid #35 of 49 in the Healthcare sector in Japan, and Grid #676 of 986 in Japan.
Which PosiPenta pillar is strongest for CellSource Co., Ltd.?
Torque (durability), with a score of 77 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for CellSource Co., Ltd.?
Nitro (momentum), with a score of 20 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.